A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer

BACKGROUND: Chemotherapy is the main therapy for stage IIIB/IV non-small cell lung cancer (NSCLC). However, the 5-year survival rate is 6%. Cancer Green Therapy is a novel therapy in China, which refers to cryoablation combined with traditional Chinese medicine (TCM) formula. Our previous retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Manqiang, Zhou, Tian, Fang, Xueni, Wang, Dan, Pang, Haoyue, Chen, Yu, Hu, Kaiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437773/
https://www.ncbi.nlm.nih.gov/pubmed/32872022
http://dx.doi.org/10.1097/MD.0000000000021626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437773/
https://www.ncbi.nlm.nih.gov/pubmed/32872022
http://dx.doi.org/10.1097/MD.0000000000021626

Ejemplares similares